Zusammenfassung
Angiotensin II (Ang II) interagiert mit dem sympathischen System auf verschiedenen Ebenen: Es steigert die exozytotische Freisetzung von Noradrenalin aus den sympathischen Varikositäten [28], erhöht die Freisetzung von Adrenalin aus dem Nebennierenmark, was einen ganglionären Angriffspunkt von Ang II nahelegt [24], es beeinflußt die Katecholaminfreisetzung im Zentralnervensystem [27] und verstärkt die Noradrenalinwirkung an der glatten Gefäßmuskulatur [3], Der letztgenannte Effekt wird dadurch ermöglicht, daß Ang II und Noradrenalin für die glattmuskuläre Kontraktion der Gefäße denselben „Second-messenger“, Inositoltriphosphat (IP3), benutzen [16]. Die geschilderten Wechselbeziehungen zwischen Ang II und dem sympathischen System lassen eine Differenzierung zwischen prä- und postsynaptischen Effekten erkennen: Zentrale, ganglionäre und postganglionäre Wirkungen an der Varikosität von Ang II am Sympathikus stehen als präsynaptische Effekte den postganglionären postsynaptischen Wirkungen an der glatten Muskulatur gegenüber.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Brasch H, Sieroslawski L, Dominiak P (1993) Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension 22:699–704
Chulak C, Couture R, Foucart S (1994) Bradykinin enhances the release of noradrenaline from rat atria through activation of a B2 receptor. Can J Physiol Pharmacol 72 (Suppl 1):458/P13.25
De Jonge A, Thoolen MJMC, Timmermans PBMWM, van Zwieten PA (1984) Interaction of angiotensin converting enzyme inhibitors with the sympathetic nervous system. Progr Pharmacol 5:25–38
Dendorfer A, Dominiak P (1995) Characterization of bradykinin receptors mediating catecholamine release in PC 12 cells. Naunyn Schmiedebergs Arch Pharmacol 351:274–281
Dominiak P (1993) Modulation of sympathetic control by ACE inhibitors. Eur Heart J 14 (Suppl I): 169–172
Dominiak T, Blöchl A (1991) Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines? Basic Res Cardiol 86 (Suppl 3): 149–156
Dominiak P, Elfrath A, Türck D (1987) Biosynthesis of catecholamines and sympathetic outflow in spontaneously hypertensive rats (SHR) after chronic treatment with CE blocking agents. J Cardiovasc Pharmacol 7:122–124
Dominiak P, Elfrath A, Türck D (1987) Effects of chronic treatment with ramipril, a new ACE blocking agent on presynaptic sympathetic nervous system of SHR. Clin Exp Hypertens A9:369–373
Dominiak P, Blöchl A, Ball B (1992) Actions of converting enzyme inhibitors on liver mitochondria of spontaneously hypertensive rats (SHR). Pharm Pharmacol Lett 2:20–23
Dominiak P, Simon M, Blöchl A, Brenner P (1992) Changes in peripheral sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and des Arg-bradykinin infusions: Influence of converting-enzyme inhibition. J Cardiovasc Pharmacol 20 (Suppl 9):S35–S38
Dominiak P, Brenner P, Simon M, Blöchl A (1994) Angiotensin I increases adrenaline release and Angiotensin II noradrenaline overflow in control and kininogen deficient Brown-Norway rats. Pharm Pharmacol Lett 4:23–26
Dzau VJ, Ingelfinger JR, Pratt RE (1986) Regulation of tissue renin and angiotensin gene expression. J Cardiovasc Pharmacol 8 (Suppl 19): 11–16
Dzau VJ, Sasamura H, Hein L (1993) Heterogeneity of angiotensin synthetic pathways and receptor subtypes: physiological and pharmacological implications. J Hypertens 11 (Suppl 3): S13–S18
Erdös EG (1976) Thekinins. Biochem Pharmacol 25:1563–1569
Göthert M, Kollecker P (1986) Subendothelial beta2-adrenoceptors in the rat vena cava: Facilitation of noradrenaline release via local stimulation of angiotensin II synthesis. Naunyn Schmiedebergs Arch Pharmacol 334:156–165
Griendling KK, Berk BC, Ganz P, Gimbrone MA Jr, Alexander W (1987) Angiotensin II stimulation of vascular smooth muscle phosphoinositide metabolism. State of the art lecture. Hypertension 9 (Suppl III): 181–185
Häuser W, Falias D, Dominiak P (1994) Bradykinin induces catecholamine release in pithed spontaneously hypertensive rates (SHR) via B2-receptors. Can J Physiol Pharmacol 72 (Suppl 2):38/P1.7
Jackson B (1993) Autoradiographische Lokalisierung von Gewebs-Angiotensin-Conversions-Enzym. Ramiprileffekte am Herzen. In: Dominiak P (Hrsg) ACE-Hemmer: Pharmakologie, lokale Wirkungen — Organprotektion und klinische Anwendung. Arcis, München
Khairallah PhA (1972) Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed Proc 31:1351–1357
Kuo Y-J, Keeton TK (1991) Captopril increases norepinephrine spillover rate in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 258:223–231
Majewski H, Hedler L, Schurr C, Starke K (1984) Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II. J Cardiovasc Pharmacol 6:888–896
Mulinari R, Benetos A, Gavras I, Gavras H (1988) Vascular and sympathoadrenal respones to Bradykinin and a Bradykinin analogue. Hypertension 11:754–757
Nussberger J, Brunner DB, Waeber B, Brunner HR (1986) Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hyptertension 8:476–482
Peach MJ (1971) Adrenal medullary stimulation induced by angiotensin I, angiotensin II and analogues. Circ Res (Suppl II):II 107–11117
Peach MJ (1977) Renin-angiotensin system (1977) Biochemistry and mechanism of action. Physiol Rev 57:313–370
Peach MJ, Bumpus FM, Khairallah PhA (1971) Release of adrenal catecholamines by angiotensin I. J Pharmacol Exp Ther 176:366–376
Qadri F, Badoer E, Stadler T, Unger Th (1991) Angiotensin II-induced noradrenaline release from anterior hypothalamus in conscious rats. A brain micro-dialysis study. Brain Res 563:137–141
Starke K (1971) Action of angiotensin on uptake, release and metabolism of 14C-noradrenaline by isolated rabbit hearts. Eur J Pharmacol 14:112–113
Starke K, Peskar BA, Schumacher KA, Taube HD (1977) Bradykinin and postganglionic sympathetic transmission. Naunyn Schmiedebergs Arch Pharmacol 299:23–32
Starke K, Taube HD, Borowski E (1977) Presynaptic receptor systems in catecholaminergic transmission. Biochem Pharmacol 26:259–268
Staszewska-Barczak J, Vane JR (1967) The release of catecholamines from the adrenal medulla by peptides. Br J Pharmacol Chemother 30:655–667
Timmermans PBMWM, Wong PC, Chiù AT et al. (1993) Angiotensin II receptors and Angiotensin II receptor antagonists. Pharmacol Rev 45:205–251
Wong PC, Price WA, Chiù AT et al. (1990) Nonpeptide angiotensin II receptor antagonists: studies with EXP 9270 and DuP 753. Hypertension 15:823–834
Zimmeramn BG (1978) Actions of angiotensin on adrenergic nerve endings. Fed Proc 37:199–202
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Dominiak, P., Sieroslawski, L., Brasch, H. (1996). Wechselwirkungen zwischen Angiotensin II und dem sympathischen System. In: Philipp, T., Schäfers, R.F. (eds) Angiotensin II — Antagonismus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79645-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-79645-6_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-59088-0
Online ISBN: 978-3-642-79645-6
eBook Packages: Springer Book Archive